CRUK - Key Persons
Appointed 2014. Andrew Palmer was formerly Group Finance Director of Legal & General plc where he had also held a number of financial and operational roles in the asset management, insurance and international businesses. He was Senior Independent Director and Chair of the Audit Committee at Royal London Group plc until March 2020 and a non-Executive Director and Chair of the Audit Committee at Direct Line Group plc until May 2018. Until April 2013 Andrew had been Senior Independent Director of SEGRO, the Industrial REIT. Andrew is also a Trustee and Chair of the Royal School of Needlework. He is a Fellow of the Institute of Chartered Accountants in England and Wales.
Appointed 2015. Carolyn Bradley has extensive marketing and commercial experience from her executive career with Tesco, where her roles included Group Brand Director, UK Marketing Director, and Chief Operating Officer for Tesco.com. She is now a non-executive Director of the SSP Group plc, B&M Value Retail S.A., Majid Al Futtaim Retail LLC and The Mentoring Foundation. In addition, she is a member of the Advisory Board for the Cambridge Judge Business School and is Chair of The Works plc. Carolyn graduated from Cambridge University before joining Tesco, where she led many innovations such as the Clubcard loyalty scheme, the ‘Every Little Helps' service campaign and the grocery home delivery business. Carolyn has also been a Trustee for the DrinkAware Trust.
Appointed 2015. Catherine Brown has broad experience in strategy and organisational change, having previously been Group Strategy Director of Lloyds Banking Group, Executive Director HR of the Bank of England, and Chief Operating Officer of Apax Partners. She is a non-executive director and chair of the remuneration committees of Metro Bank plc and QBE (UK) Ltd. She sits on the board of FNZ (UK), a private equity backed financial services technology company, and is Chairman of Additive Flow Ltd. Catherine was a non-executive board member of the Cabinet Office until March 2020. She is a trustee of Blue Cross and also has charity projects across the Himalayan region. She spent her early career as a banker before joining McKinsey and subsequently ran her own management consultancy for five years before moving into private equity at Apax Partners.
Job Titles:
- Research Programme Manager for ED & D Trials, Health Systems and Behavioural Research
Job Titles:
- Member of the Discovery Research Committee
- Member of Committee
Job Titles:
- Member of the Discovery Research Committee
- Member of Committee
Job Titles:
- Head of Prevention and Early Detection Research
Job Titles:
- Member of the Discovery Research Committee
- Member of Committee
Job Titles:
- Member of the Discovery Research Committee
- Head of Careers and Discovery Research
- Member of Committee
Job Titles:
- Member of the Discovery Research Committee
- Member of Committee
Job Titles:
- Member of the NAC
- Guy 's & St Thomas NHS Foundation Trust
Job Titles:
- Trustee
- ARCS DPhil FCGI ( Treasurer )
Appointed 2020. Dr Robert Easton is a former Partner of Carlyle, the global alternative asset management company. During his 19 years at the firm he performed a number of roles as an investment professional, being a fund head in buyout and technology investing, while serving on multiple portfolio company boards. Robert is a past Chairman of the British Venture Capital Association and a serial investor in technology driven, small and start-up businesses. He has had a variety of engagements with the higher education sector at Oxford University, where until recently he was a Pro-Vice-Chancellor, as well as at Imperial College. In addition to being a Trustee of CRUK, Robert is a Fellow of the British Heart Foundation and a Trustee of the Young Vic Theatre and funds causes in science, sport, music, higher education, conservation and sub-Saharan Africa.
Job Titles:
- Research Programme Manager for ED & D Markers, Technology and Data
Job Titles:
- Member of the Discovery Research Committee
- Professor of Biochemistry
Gerard is an established independent researcher in basic and translational research who is funded by our Discovery Research Committee.
Appointed 2020. Professor Moira Whyte is Vice-Principal and Head of the College of Medicine and Veterinary Medicine and the Sir John Crofton Professor of Respiratory Medicine at the University of Edinburgh. She was formerly Director of the MRC/University of Edinburgh Centre for Inflammation Research and Head of Edinburgh Medical School. She is a member of MRC Strategy Board and Chair of the MRC Training and Careers Group and is also Chair of Sub-panel 1 (Clinical Medicine) for the UK's Research Excellence Framework (REF)2021. Her research interests are in basic mechanisms of innate immunity in the context of chronic lung diseases.
Job Titles:
- Member of the Clinical Research Committee
- Patient Representative
Job Titles:
- Member of the Clinical Research Committee
- Patient Representative
Job Titles:
- Member of the Clinical Research Committee
- Patient Representative
Job Titles:
- Chairman of Clinical Paediatric Oncology at the University of Birmingham
Appointed 2021. Professor Pamela Kearns is Chair of Clinical Paediatric Oncology at the University of Birmingham and an Honorary Consultant Paediatric Oncologist at Birmingham Women and Children's Hospital. She is Director of the University of Birmingham's Institute of Cancer and Genomic Sciences and Director of the Cancer Research UK Clinical Trials Unit (CRCTU). As Director of CRCTU, she leads the research strategy for one of UK's largest cancer trials unit, delivering a trials portfolio of over 100 multi-centre & international cancer trials for a wide range of cancers, occurring in all children, young people and adults. She was elected President of the European Society of Paediatric Oncology (SIOP Europe) in 2019, having been a Board member since 2013. She has several European roles including Executive Board Member of the academic consortium ‘Innovative Therapeutics in Childhood Cancer' (ITCC), Chair of ITCC's European Sponsor Institutions Committee and Steering Committee member of the International multi-stakeholder platform ‘ACCELERATE'. Her research interests are focussed on drug development and innovation of design and delivery of clinical trials for childhood cancers. She was also a Senior Clinical Advisor to Cancer Research UK from 2015 to 2020 and is a Trustee of a Child of Mine, a charity dedicated to supporting bereaved parents.
Job Titles:
- Trustee
- Chairman of Cancer Research Technology Ltd
Appointed 2016. Peter Chambré is Chair of Cancer Research Technology Ltd, the commercialisation arm of Cancer Research UK and Immatics N.V., a company developing new cancer immunotherapy treatments. He has been a director of a number of public and private healthcare and life science companies, and was Chief Executive Officer of Cambridge Antibody Technology plc from 2002 until its acquisition by AstraZeneca in July 2006. Peter is a Director of Our Future Health.
Appointed 2018. Tracy De Groose has broad marketing and commercial experience in leadership roles across the creative industries. Until recently, Tracy was chair of Newsworks, the marketing arm for the UK news publishing industry. Prior to that Tracy was chief executive of Dentsu UK & Ireland with P&L responsibility for over 20 media, digital and data businesses and 4,000 people, working with a diverse range of clients including Disney, Diageo, Asda and the UK government. In 2020, Tracy founded ‘Brilliant Misfits' to advise the next generation of business leaders and entrepreneurs to help accelerate positive change. Tracy prioritises time to mentor, support and guide emerging talent and was invited to join the World Economic Forum's innovation and entrepreneurship council 2015-2017.